Cardiology

Remission of T2D, regardless of duration of remission, was associated with reduced risk of diabetes-related CKD and CVD in a post hoc analysis of Look AHEAD.

The protective effect of bempedoic acid appeared to increase with the number of CV events a study participant experienced, according to study authors.

Findings from new study suggest that promoting healthy coping strategies for stress during early life can reduce cardiometabolic risk, report researchers.

Compared to the lowest intake of AS-rich food and beverages, the highest intake was associated with a 59% higher risk of developing MetS, according to new findings.

The risk of severe CV events, including leading to death, was greatest in the first week following an exacerbation but remained significantly elevated 1 year later.

In an open letter to the public, Lilly decries use of tirzepatide products Mounjaro and Zepbound for nonmedical purposes and warns of counterfeit formulations.

While not eliminated, study authors found risk of VTE reduced roughly by half in women taking vs not taking a statin when initiating hormone therapy.

Your daily dose of the clinical news you may have missed.

The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.

Your daily dose of the clinical news you may have missed.

Twins randomly assigned to a plant-based diet had significant decreases in LDL-C concentration, fasting insulin levels, and body weight.

Statin use remained at only 35% among eligible adults since updated guidelines from ACC/AHA on cholesterol treatment.

The 10 most important take-homes from the 2023 ACC/AHA AF guidelines are summarized in this Guideline Topline, an at-a-glance preview for primary care.

Your daily dose of the clinical news you may have missed.

The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.

Simplified risk stratification tools for NAFLD, effects of statins on hepatic disease, trends in OHE, and patient perspectives are samples of the noteworthy research areas.

The revised guidance classifies AF into 4 stages, emphasizes prevention and aggressive rhythm control, and upgrades recommendations for catheter ablation and LAA occlusion.

Which antihypertensive therapy options are most and least effective for patients with migraine? Get details, here.

Identifying women at risk for preeclampsia with severe features and the most effective treatment is essential to reduce morbidity as well as to contain costs.

Your daily dose of the clinical news you may have missed.

Review the ACC/AHA guidelines on prevention of ASCVD through lifestyle and risk factor assessment and management in our at-a-glance slide show.

Cardiovascular mortality has been increasing among middle-aged US adult since 2011; a new study looked at changes in CV risk factors by income level over the past 20 years.

Your daily dose of the clinical news you may have missed.

Chiadi Ndumele, MD, PhD, MHS, offers 3 thoughts for primary care on incorporating CKM syndrome screening into daily clinical practice.

An obesity specialist discusses the importance of using a weight-first approach when educating patients about obesity's role in the development and worsening of hypertension.

The novel oral anticoagulant is one in a class of agents for prevention of AF-related stroke that shows promise to reduce bleeding risk.